Literature DB >> 18751946

Application of cyclophosphamide-induced tolerance in alpha1,3-galactosyltransferase knockout mice presensitized with Gal alpha 1-3Gal beta-4-GlcNAc antigens.

Tatsushi Onzuka1, Ichiro Shimizu, Yukihiro Tomita, Toshiro Iwai, Shinji Okano, Ryuji Tominaga.   

Abstract

PURPOSE: Hyperacute rejection (HAR) mediated by the natural antibody (nAb) against Gal alpha 1-3Gal beta-4-GlcNAc (alpha Gal) is the major obstacle in xenogeneic organ transplantation. Previously, we reported the acceptance of donor heart grafts in anti-alpha Gal nAb-producing galactosyltransferase knockout (GalT KO) mice after cyclophosphamide (CP)-induced tolerance conditioning. In the present study, we applied our tolerance induction conditioning in presensitized recipient mice.
METHODS: GalT KO (alpha Gal(-/-), H-2(b/d)) recipient mice were presensitized with alpha Gal(+) rabbit red blood cells (RRBCs). Presensitized or nonsensitized recipient mice were treated with CP-induced tolerance conditioning, consisting of AKR (alpha Gal(+/+), H-2(k)) spleen cells (SC), CP, busulfan (BU), and AKR bone marrow cells (BMC). We assessed the survival of donor hearts and skin grafts and analyzed the production of anti-alpha Gal Abs by flow cytometry.
RESULTS: Donor mixed chimerism was achieved in the presensitized GalT KO mice treated with CP-induced tolerance conditioning. In parallel with the disappearance of anti-alpha Gal Abs, permanent acceptance of donor heart grafts and skin grafts was observed in presensitized and GalT KO mice treated with CP-induced tolerance conditioning.
CONCLUSIONS: Both B-cell and T-cell tolerance was achieved in the presence of a higher titer of anti-alpha Gal Abs after treatment with CP-induced tolerance conditioning.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18751946     DOI: 10.1007/s00595-007-3715-1

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  52 in total

1.  Application of chimerism-based drug-induced tolerance to rat into mouse xenotransplantation.

Authors:  Y Tomita; I Shimizu; T Iwai; Q-W Zhang; S Okano; T Kajiwara; T Onzuka; R Tominaga
Journal:  Scand J Immunol       Date:  2006-10       Impact factor: 3.487

2.  Efficacy and limitations of cyclophosphamide-induced tolerance against alphaGal antigen.

Authors:  I Shimizu; Y Tomita; T Iwai; T Kajiwara; S Okano; K Sueishi; K Nomoto; H Yasui
Journal:  Scand J Immunol       Date:  2005-09       Impact factor: 3.487

3.  Decomplementation with cobra venom factor prolongs survival of xenografted islets in a rat to mouse model.

Authors:  J Oberholzer; D Yu; F Triponez; N Cretin; E Andereggen; G Mentha; D White; L Buehler; P Morel; J Lou
Journal:  Immunology       Date:  1999-05       Impact factor: 7.397

4.  Improved technique of heterotopic cervical heart transplantation in mice.

Authors:  Y Tomita; Q W Zhang; M Yoshikawa; T Uchida; K Nomoto; H Yasui
Journal:  Transplantation       Date:  1997-12-15       Impact factor: 4.939

5.  Pancreatic islet xenograft tolerance after short-term costimulation blockade is associated with increased CD4+ T cell apoptosis but not immune deviation.

Authors:  A M Lehnert; S Yi; J S Burgess; P J O'Connell
Journal:  Transplantation       Date:  2000-03-27       Impact factor: 4.939

6.  Protection of hDAF-transgenic porcine endothelial cells against activation by human complement: role of the membrane attack complex.

Authors:  Wolfgang Fecke; Joanna Long; Andrew Richards; Richard Harrison
Journal:  Xenotransplantation       Date:  2002-03       Impact factor: 3.907

7.  Evidence for involvement of clonal anergy in MHC class I and class II disparate skin allograft tolerance after the termination of intrathymic clonal deletion.

Authors:  Y Tomita; Y Nishimura; N Harada; M Eto; K Ayukawa; Y Yoshikai; K Nomoto
Journal:  J Immunol       Date:  1990-12-15       Impact factor: 5.422

8.  Intrathymic clonal deletion of V beta 6+ T cells in cyclophosphamide-induced tolerance to H-2-compatible, Mls-disparate antigens.

Authors:  M Eto; H Mayumi; Y Tomita; Y Yoshikai; K Nomoto
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

9.  Prolonged survival of rat islet and skin xenografts in mice treated with donor splenocytes and anti-CD154 monoclonal antibody.

Authors:  E J Gordon; T G Markees; N E Phillips; R J Noelle; L D Shultz; J P Mordes; A A Rossini; D L Greiner
Journal:  Diabetes       Date:  1998-08       Impact factor: 9.461

10.  A murine model of antibody-mediated hyperacute rejection by galactose-alpha(1,3)galactose antibodies in Gal o/o mice.

Authors:  I F McKenzie; Y Q Li; K Patton; A D Thall; M S Sandrin
Journal:  Transplantation       Date:  1998-09-27       Impact factor: 4.939

View more
  1 in total

1.  Current status of and prospects for the English medical journal Surgery Today.

Authors:  Yoshihiko Maehara; Yoshihiro Kakeji
Journal:  Surg Today       Date:  2010-12       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.